Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,862 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictive modelling of the effectiveness of vaccines against COVID-19 in Bogotá: Methodological innovation involving different variants and computational optimisation efficiency.
Espinosa O, White L, Bejarano V, Aguas R, Rincón D, Mora L, Ramos A, Sanabria C, Rodríguez J, Barrera N, Álvarez-Moreno C, Cortés J, Saavedra C, Robayo A, Gao B, Franco O. Espinosa O, et al. Among authors: cortes j. Heliyon. 2024 Oct 23;10(21):e39725. doi: 10.1016/j.heliyon.2024.e39725. eCollection 2024 Nov 15. Heliyon. 2024. PMID: 39559218 Free PMC article.
Results of a patient-level pooled analysis of three studies of trastuzumab deruxtecan in HER2-positive breast cancer with active brain metastasis.
Bartsch R, Pérez-García JM, Furtner J, Berghoff AS, Marhold M, Starzer AM, Hughes M, Kabraji S, Sammons S, Anders C, Murthy RK, Van Swearingen AED, Pereslete A, Gion M, Vaz Batista M, Braga S, Pinto PBC, Sampayo-Cordero M, Llombart-Cussac A, Preusser M, Cortés J, Lin NU. Bartsch R, et al. Among authors: cortes j. ESMO Open. 2025 Jan 3;10(1):104092. doi: 10.1016/j.esmoop.2024.104092. Online ahead of print. ESMO Open. 2025. PMID: 39754978 Free article.
Dysregulation of mTOR signalling is a converging mechanism in lissencephaly.
Zhang C, Liang D, Ercan-Sencicek AG, Bulut AS, Cortes J, Cheng IQ, Henegariu O, Nishimura S, Wang X, Peksen AB, Takeo Y, Caglar C, Lam TT, Koroglu MN, Narayanan A, Lopez-Giraldez F, Miyagishima DF, Mishra-Gorur K, Barak T, Yasuno K, Erson-Omay EZ, Yalcinkaya C, Wang G, Mane S, Kaymakcalan H, Guzel A, Caglayan AO, Tuysuz B, Sestan N, Gunel M, Louvi A, Bilguvar K. Zhang C, et al. Among authors: cortes j. Nature. 2025 Jan 1. doi: 10.1038/s41586-024-08341-9. Online ahead of print. Nature. 2025. PMID: 39743596
HER2DX genomic test in early-stage HER2-positive breast cancer.
Tolaney SM, Tung N, Wolff AC, DeMichele A, Cejalvo JM, Martínez-Sáez O, Pascual T, Waks AG, Martín M, Ciruelos E, Harbeck N, Carey LA, Cortés J, Curigliano G, Prat A. Tolaney SM, et al. Among authors: cortes j. ESMO Open. 2024 Dec;9(12):103987. doi: 10.1016/j.esmoop.2024.103987. Epub 2024 Nov 16. ESMO Open. 2024. PMID: 39710442 Free PMC article. Review.
Evidence-based clinical standard for the diagnosis and treatment of candidemia in critically ill patients in the intensive care unit.
Cortés JA, Valderrama-Rios MC, Peçanha-Pietrobom PM, Júnior MS, Diaz-Brochero C, Robles-Torres RR, Espinosa-Almanza CJ, Nocua-Báez LC, Nucci M, Álvarez-Moreno CA, Queiroz-Telles F, Rabagliati R, Rojas-Fermín R, Finquelievich JL, Riera F, Cornejo-Juárez P, Corzo-León DE, Cuéllar LE, Zurita J, Hernández AR, Colombo AL. Cortés JA, et al. Braz J Infect Dis. 2024 Dec 21;29(1):104495. doi: 10.1016/j.bjid.2024.104495. Online ahead of print. Braz J Infect Dis. 2024. PMID: 39709887 Free article.
Efficacy and safety of antibody-drug conjugates in pretreated HER2-low metastatic breast cancer: A systematic review and network meta-analysis.
Schettini F, Nucera S, Pascual T, Martínez-Sáez O, Sánchez-Bayona R, Conte B, Buono G, Lambertini M, Punie K, Cejalvo JM, Arpino G, Vigneri P, Generali D, Ciruelos E, Cortés J, Gennari A, Muñoz M, Vidal Losada MJ, Tolaney SM, Prat A, Villacampa G. Schettini F, et al. Among authors: cortes j. Cancer Treat Rev. 2025 Jan;132:102865. doi: 10.1016/j.ctrv.2024.102865. Epub 2024 Dec 19. Cancer Treat Rev. 2025. PMID: 39709655 Free article. Review.
Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2+ early breast cancer (EBC).
Fernandez-Martinez A, Tanioka M, Ahn SG, Zagami P, Pascual T, Rediti M, Tang G, Hoadley KA, Venet D, Rashid NU, Spears PA, Di Cosimo S, de Azambuja E, Choudhury A, Rastogi P, Islam MN, Cortes J, Llombart-Cussac A, Swain SM, Sotiriou C, Prat A, Perou CM, Carey LA. Fernandez-Martinez A, et al. Among authors: cortes j. Ann Oncol. 2024 Dec 18:S0923-7534(24)04989-5. doi: 10.1016/j.annonc.2024.12.010. Online ahead of print. Ann Oncol. 2024. PMID: 39706338 Free article.
2,862 results